JP2008519854A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519854A5
JP2008519854A5 JP2007541376A JP2007541376A JP2008519854A5 JP 2008519854 A5 JP2008519854 A5 JP 2008519854A5 JP 2007541376 A JP2007541376 A JP 2007541376A JP 2007541376 A JP2007541376 A JP 2007541376A JP 2008519854 A5 JP2008519854 A5 JP 2008519854A5
Authority
JP
Japan
Prior art keywords
application
awarded
government
health
entirety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007541376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519854A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/041037 external-priority patent/WO2006053252A2/en
Publication of JP2008519854A publication Critical patent/JP2008519854A/ja
Publication of JP2008519854A5 publication Critical patent/JP2008519854A5/ja
Withdrawn legal-status Critical Current

Links

JP2007541376A 2004-11-12 2005-11-14 ヌクレオシドアナログ剤を用いて血液悪性疾患を治療する方法 Withdrawn JP2008519854A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62686204P 2004-11-12 2004-11-12
PCT/US2005/041037 WO2006053252A2 (en) 2004-11-12 2005-11-14 Methods of treating hematological malignancies with nucleoside analog drugs

Publications (2)

Publication Number Publication Date
JP2008519854A JP2008519854A (ja) 2008-06-12
JP2008519854A5 true JP2008519854A5 (https=) 2008-08-28

Family

ID=36337278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007541376A Withdrawn JP2008519854A (ja) 2004-11-12 2005-11-14 ヌクレオシドアナログ剤を用いて血液悪性疾患を治療する方法

Country Status (6)

Country Link
US (1) US20090082304A1 (https=)
EP (1) EP1814390A4 (https=)
JP (1) JP2008519854A (https=)
AU (1) AU2005304320A1 (https=)
CA (1) CA2596543A1 (https=)
WO (1) WO2006053252A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128299A1 (en) * 2007-04-24 2008-10-30 Murdoch Childrens Research Institute Therapeutic protocol for treating hemoglobinopathy
SG176571A1 (en) * 2009-05-19 2012-01-30 Vivia Biotech Sl Methods for providing personalized medicine tests ex vivo for hematological neoplasms
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
US20220249534A1 (en) * 2021-02-11 2022-08-11 Massachusetts Institute Of Technology Method of treating cancer with nucleotide therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
EP0642347A4 (en) * 1992-05-19 1997-06-18 Scripps Research Inst USE OF 2-HALO-ADENINE DERIVATIVES AS THERAPEUTIC ACTIVE AGENTS AGAINST CHRONIC-MYELOIC LEUKEMIA.

Similar Documents

Publication Publication Date Title
JP2010502545A5 (https=)
JP2010538767A5 (https=)
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
JP2006503588A5 (https=)
JP2008501714A5 (https=)
CY1114690T1 (el) Αντισωματα αντι-nrr notch1 και μεθοδοι χρησεις αυτων
ATE491700T1 (de) KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D-
JP2011517716A5 (https=)
JP2009541403A5 (https=)
JP2011519271A5 (https=)
NO20080412L (no) Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
JP2007511626A5 (https=)
JP2007520565A5 (https=)
JP2008278122A5 (https=)
JP2009504909A5 (https=)
JP2008542528A5 (https=)
JP2005536763A5 (https=)
JP2008519854A5 (https=)
JP2009532412A5 (https=)
JP2008519810A5 (https=)
JP2007523200A5 (https=)
JP2011057638A5 (https=)
JP2004526429A5 (https=)
JP2007531613A5 (https=)
JP2009509934A5 (https=)